VIRIONZA Influenza Vaccine 15µg/0.5mL

VIRIONZA Influenza Vaccine 15µg/0.5mL is a split-virion, inactivated influenza vaccine designed to help prevent seasonal influenza caused by vaccine-related influenza virus strains. It contains purified and inactivated influenza virus antigens prepared from influenza A and B strains recommended for the applicable influenza vaccine season.

The vaccine is manufactured using influenza virus strains propagated in embryonated chicken eggs, followed by inactivation, concentration, purification, and splitting processes. It contains 15 µg of hemagglutinin from each included influenza strain per 0.5 mL dose and is supplied as a convenient single-dose pre-filled syringe.

VIRIONZA is intended for eligible individuals, including children aged 3 years and above, particularly people who may be at increased risk of influenza-related complications. Vaccination should be administered by a qualified healthcare professional after assessing the individual's suitability.

Active Ingredients

Each 0.5 mL dose contains hemagglutinin from the following influenza virus strains:

• A/Victoria/4897/2022 (H1N1)pdm09-like virus — 15 µg hemagglutinin
• A/Croatia/10136RV/2023 (H3N2)-like virus — 15 µg hemagglutinin
• B/Austria/1359417/2021 (B/Victoria lineage)-like virus — 15 µg hemagglutinin

The vaccine contains no preservatives or antibiotics, according to the supplied product information.

Uses & Indications

VIRIONZA is used for the prevention of seasonal influenza caused by influenza virus strains related to those included in the vaccine.

It may be recommended for eligible individuals, particularly those who are at increased risk of influenza complications, including:

• Children aged 3 years and above
• Older adults
• Individuals considered vulnerable to influenza complications
• People living in or travelling to areas experiencing influenza activity

After vaccination, the vaccine stimulates the body's immune system to develop protection against the influenza virus strains included in the vaccine.

Dosage & Administration

VIRIONZA is administered as an intramuscular injection by a qualified healthcare professional.

The appropriate vaccination schedule and dose should be determined according to the individual's age, medical circumstances, vaccination history, and the recommendations applicable to the current influenza season.

Do not self-administer. Consult your doctor or pharmacist before vaccination.

Key Features

• Influenza Vaccine (Split Virion), Inactivated
• Contains 15 µg hemagglutinin per included strain
• 0.5 mL single-dose pre-filled syringe
• Helps prevent seasonal influenza
• Contains influenza A and B antigens
• Suitable for eligible individuals 3 years and above
• Administered by a qualified healthcare professional
• No preservatives or antibiotics, according to product information
• Convenient single-dose presentation

Product Specifications

Storage Instructions

Store VIRIONZA Influenza Vaccine in a refrigerator at 2°C–8°C.

• Do not freeze.
• Protect from sunlight.
• Keep refrigerated until use.
• Follow the storage instructions provided with the product.

Important Information

VIRIONZA should only be administered under the supervision of a qualified healthcare professional. Consult your doctor or pharmacist before vaccination, particularly if you have a history of severe allergic reactions to vaccines or vaccine components.

Vaccine strains, availability, batch number, expiry date, and other product details may vary according to the applicable influenza season.

Prescription/Professional Use: Administration should be carried out by a qualified healthcare professional.